Is the machine fully automatic?

Yes, the machine features a fully automatic automation level.

What is the production capacity?

Capacity ranges from 30-50 kg/time for BYC-800 to 80-150 kg/time for BYC-1200.

Pharmaceutical Pill Peanut Sugar Powder Spray Tablet Seed Powder Coating Machine

Name: Pharmaceutical Pill Peanut Sugar Powder Spray Tablet Seed Powder Coating Machine
Brand: Foshan Dale Machinery Co., Ltd.
SKU: 1985204445

Guangdong, ChinaFoshan Dale Machinery Co., Ltd.

US$1,300.00

1 Piece

Product profile

Customization

Available

Automation Level

Fully Automatic

Certification

CE, GMP

Model NO.

BYC-300

Tablet Shape

Oval, Rectangular, Round, Square

Warranty

1 Year

Material

Stainless Steel

Finished Dosage Form

Tablet

Precision

High Precision

Voltage

220V

Condition

New

Type

Coating Machine

Transport Package

Wooden

Specification

460x325x700mm

Trademark

Xingle

Origin

China

HS Code

843880000

Production Capacity

100sets/Month

Key features

Fully Automatic Operation: Integrates electric, hydraulic, and pneumatic systems for automated coating.

High Precision Coating: Ensures uniform film formation with smooth and dense tablet surfaces.

CE and GMP Certified: Meets international safety and pharmaceutical manufacturing standards.

Customizable Spray Gun: Spray gun specifications can be tailored according to client needs.

Stainless Steel Construction: Made from high-quality stainless steel for durability and hygiene.

Multiple Shape Options: Suitable for coating oval, rectangular, round, and square tablets.

Variable Speed Control: Motor frequency control allows precise adjustment of coating speed.

Integrated Hot Air System: Simultaneous drying and coating with controlled hot air temperature.

Company profile

Foshan Dale Machinery Co., Ltd.

Guangdong, China

Business Type: Manufacturer/Factory, Trading CompanyAverage Response Time: ≤2.46h

AI-Powered supplier vetting

SummaryThe supplier manufactures pharmaceutical filling, sealing, production-line, testing, and packaging equipment, including capsule, ampoule, oral-liquid, eye-drop, injectable, ointment, suppository, and spray machinery. It reports broad customization, ODM capability, new product activity, and one R&D engineer. Products are stated to comply with FDA, GMP, cGMP, and CE-related requirements, although the evidence does not establish the scope or validity of each certification. After-sales support includes technical support, installation, commissioning, and service through direct customers and foreign agencies, but no overseas warehouse, showroom, or branch is reported. Financial records are referenced for 2022–2024, but their results are not provided. The supplier has exported for five years and reports OEM service for known brands, while no Fortune 500 collaboration is reported. Quality-control complaint and corrective-action procedures lack written records, and raw-material traceability is unknown.

Supplier typeThe supplier is an industrial pharmaceutical-equipment manufacturer offering filling, sealing, production-line, testing, and packaging machinery. Its description also states that products are manufactured in accordance with international standards and exported to multiple countries.

CertificationsThe supplier states that its machines are manufactured according to FDA, GMP, and cGMP standards and identifies CE as a product compliance certification. However, the slices do not provide certificate numbers, issuing bodies, validity periods, or product-specific coverage.

After-Sales capabilityTechnical support, installation, commissioning, and after-sales service are stated, and the supplier reports direct customers and foreign agencies. However, it has no overseas warehouse, showroom, or overseas branch, while complaint handling and corrective/preventive-action processes have no written procedures or records.

R&D capabilityThe supplier reports new products during the past year, ODM capability, broad design services, and one R&D engineer. It does not have an available SDK, and the limited staffing information does not establish the scale or depth of its innovation resources.

Production capacityThe supplier lists a broad range of pharmaceutical machinery and states that its machines are exported internationally and manufactured to cited international standards. It also reports in-stock capacity and lead times of one month or within 15 workdays, but no production volume or facility capacity is provided.

Customization capabilityThe supplier explicitly offers customization from designs, full customization, customization from samples, minor customization, and flexible customization. It also reports ODM service availability, providing direct evidence of broad customization capability.

Client casesThe supplier reports OEM service for known brands, established relationships with many direct customers, and agencies abroad, and states that its products have been exported to many countries. It reports no cooperation with Fortune 500 companies, and no named customer cases or independently verifiable project details are provided.